XORTX Therapeutics Inc. (NASDAQ:XRTX) Short Interest Up 79.0% in April

XORTX Therapeutics Inc. (NASDAQ:XRTXGet Free Report) was the recipient of a large increase in short interest in the month of April. As of April 30th, there was short interest totaling 79,644 shares, an increase of 79.0% from the April 15th total of 44,502 shares. Based on an average trading volume of 6,498,507 shares, the short-interest ratio is currently 0.0 days. Approximately 6.1% of the shares of the stock are sold short.

XORTX Therapeutics Stock Performance

Shares of XRTX stock opened at $2.32 on Wednesday. The stock’s fifty day moving average price is $2.33 and its two-hundred day moving average price is $2.60. The company has a market cap of $3.60 million, a PE ratio of -0.88 and a beta of 0.80. XORTX Therapeutics has a fifty-two week low of $1.73 and a fifty-two week high of $7.05.

XORTX Therapeutics (NASDAQ:XRTXGet Free Report) last issued its earnings results on Friday, May 15th. The technology company reported ($0.58) earnings per share for the quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of XORTX Therapeutics in a research note on Friday, March 27th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has an average rating of “Sell”.

View Our Latest Analysis on XRTX

Institutional Investors Weigh In On XORTX Therapeutics

A hedge fund recently bought a new stake in XORTX Therapeutics stock. DRW Securities LLC acquired a new stake in shares of XORTX Therapeutics Inc. (NASDAQ:XRTXFree Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 193,599 shares of the technology company’s stock, valued at approximately $109,000. DRW Securities LLC owned approximately 2.78% of XORTX Therapeutics as of its most recent SEC filing. Institutional investors and hedge funds own 0.23% of the company’s stock.

About XORTX Therapeutics

(Get Free Report)

Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers.

Read More

Receive News & Ratings for XORTX Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XORTX Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.